...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Shareholders

Toinv, according to Simply WallSt Eastern is the single largest shareholder of ZCC @ 36.95%

Total Outstanding Common Shares 135,295,827.

General Public owns 62,607,643 (46.3%)

Top 13 shareholders own 53.73% of the company
Ownership Name Shares Current Value Change % Portfolio %  
36.95% Eastern Capital Limited 49,989,140 $12.5m 0% 9.95%  
9.71% NGN Capital 13,142,692 $3.3m 0% 69.92%  
3.04% Donald McCaffrey 4,112,189 $1.0m 0% no data  
2.33% Norman Wong 3,154,959 $788.7k 0% no data  
0.89% Charalambos Katevatis 1,200,001 $300.0k 0% no data  
0.19% Aaron Cann 253,023 $63.3k 0% no data  
0.17% Eldon Smith 231,000 $57.8k 0% no data  
0.17% Kenneth Zuerblis 230,537 $57.6k 0% no data  
0.098% Dimensional Fund Advisors L.P. 133,050 $33.3k -0.97% no data  
0.088% Henrik Hansen 118,437 $29.6k 0% no data  
0.052% Kelly McNeill 70,000 $17.5k 0% no data  
0.036% Sanjay Lakhotia 48,656 $12.2k 0% no data  
0.0033% Steward Partners Investment Advisory, Llc 4,500 $1.1k 0% no data

 

Koo

Share
New Message
Please login to post a reply